CompletedEUCTR 2009-015629-35

Open-label, single arm, interventional study to explore the efficacy and safety of paliperidone ER in the management of patients with acute agitation and/or aggression

This historical record does not confirm current site availability.

Historical research recordBelgiumSchizophrenia

The study in practice

Understand this study

What did researchers investigate?

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments. Check the source details below for country statuses and any transfer to CTIS.

Listed locations: Belgium
Study phase: Phase 4

Get this study by email

Study clarity

Study information

Study start dateNot clearly listed

Recruitment status: Completed
Enrollment listed in the registry: Not clearly listed
Sponsor: Janssen-Cilag NV/SA
Sponsor type: Other organization
Study type: Drug
Intervention type: Drug
Study phase: Phase 4
Locations: Belgium
Age range: Not clearly listed
Official registry ID: EUCTR 2009-015629-35
Official title: Show the full official title
Open-label, single arm, interventional study to explore the efficacy and safety of paliperidone ER in the management of patients with acute agitation and/or aggression

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

Belgium

Registry details

Historical country statuses

Belgium — Completed

Interested in joining this study?

FAQ

Questions about this study

Who is behind this study?

The study sponsor is Janssen-Cilag NV/SA.

Want to explore more studies?

Explore studies